Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Dimerix (ASX:DXB) Completes Adult Recruitment in ACTION3

DMX-200 is an investigational therapy for focal segmental glomerulosclerosis (FSGS), a kidney disease associated with protein loss in urine and declining kidney function. Dimerix is evaluating whether the treatment reduces proteinuria compared with placebo. A separate FSGS treatment received US approval in 2026, changing …

Sonal Goyal | 29 September 2026

SomnoMed (ASX:SOM) Expands Virtus Distribution

SomnoMed designs and manufactures custom oral appliances used to treat obstructive sleep apnoea and snoring, positioned as an alternative to continuous positive airway pressure, or CPAP, machines for patients who find CPAP masks uncomfortable or difficult to tolerate long-term. Because oral appliances work by …

Sonal Goyal | 29 September 2026

Chimeric Therapeutics (ASX:CHM) Stops CHM-2101 Enrolment After Safety Review

Chimeric Therapeutics is a clinical-stage cell therapy company built around chimeric antigen receptor, or CAR-T, technology aimed at solid and haematological cancers that have proven difficult to treat with earlier generations of immunotherapy. Solid tumours in particular have historically been harder for CAR-T approaches …

Sonal Goyal | 29 September 2026

Micro-X (ASX:MX1) Reports FY26 Revenue as It Develops Portable Imaging

Micro-X designs and manufactures compact, lightweight X-ray systems built around proprietary carbon nanotube emitter technology, which allows imaging hardware to be made significantly smaller and lighter than conventional X-ray tube-based systems. The company's products target mobile and point-of-care imaging use cases — including hospital …

Sonal Goyal | 29 September 2026

Proteomics International (ASX:PIQ) Advances PromarkerD Distribution

Proteomics International operates a Perth-based analytical laboratory accredited to ISO 15189 and ISO 17025 standards, alongside a portfolio of proprietary protein biomarker tests. Its lead product, PromarkerD, is a prognostic blood test that predicts the risk of diabetes-related chronic kidney disease up to four …

Sonal Goyal | 29 September 2026

CurveBeam AI (ASX:CVB) Reports Receipts While Awaiting China Registration

CurveBeam AI develops specialised CT scanners and AI-enabled clinical assessment software for musculoskeletal imaging, with corporate functions in Melbourne and global headquarters in Hatfield, Pennsylvania, employing more than 70 staff. Its flagship HiRise system is a CT scanner capable of both weight-bearing and conventional …

Sonal Goyal | 29 September 2026

EBR Systems (ASX:EBR) Funds the Commercial Rollout of Its WiSE CRT System

EBR Systems develops the WiSE (Wireless Stimulation Endocardially) CRT System. It delivers wireless pacing to the left ventricle, avoiding the conventional coronary sinus lead used for that part of cardiac resynchronisation therapy. Patients may still require other cardiac devices or leads. The company trades …

Sonal Goyal | 29 September 2026

Botanix Pharmaceuticals (ASX:BOT) Adds a Sofdra Patent Allowance to Its IP Portfolio

Botanix has transitioned from a clinical-stage developer into what the company itself now describes as a commercial dermatology business, built around Sofdra (sofpironium bromide), a topical treatment approved by the US FDA for primary axillary hyperhidrosis — excessive underarm sweating — in adults and …

Sonal Goyal | 29 September 2026

Vitura Health (ASX:VIT) Reports Telehealth EBITDA and a Group Loss

Vitura Health operates across several linked parts of the Australian healthcare access market, combining its Doctors on Demand telehealth service with pharmacy and medicinal cannabis distribution operations. The strategic logic behind the combination is that a telehealth consultation can lead directly into a prescription …

Sonal Goyal | 29 September 2026

Invion (ASX:IVX) Expands Photosoft Licensing Rights

Invion develops photodynamic therapy, or PDT, a treatment approach in which a photosensitising drug is administered and then selectively activated by light at the treatment site, generating a localised therapeutic effect while aiming to spare surrounding healthy tissue. The company's Photosoft platform has been …

Sonal Goyal | 29 September 2026
Support

Hi! How can we help you today?

Loading…